Skip to main content

Advertisement

SpringerLink
Log in

Invited commentary

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bellet, R.E., Catalano, R.B., Mastrangelo, M.J., Berd, O.: Positive phase II trial of dibromodulcital in patients with metastatic melanoma refractory to DTIC and a nitrosourea. Cancer Treat. Rep.62:2095, 1978

    Google Scholar 

  2. Tannock, I.: Cell kinetics and chemotherapy: a critical review. Cancer Treat. Rep.62:1117, 1978

    Google Scholar 

  3. Barranco, S.C., Luce, J.K., Romsdahl, M.M., Humphrey, R.M.: Bleomycin as a possible synchronizing agent for human tumor cells in vivo. Cancer Res.33:882, 1973

    Google Scholar 

  4. Terasima, T., O'Hara, H., Miyamoto, T. et al: Cell cycle dependent response and combined treatment of tumor. Jpn. J. Antibiot.30[Suppl.]:49, 1977

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adria Laboratories, Columbus, Ohio, USA

    James K. Luce M.D.

Authors
  1. James K. Luce M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luce, J.K. Invited commentary. World J. Surg. 3, 327–328 (1979). https://doi.org/10.1007/BF01556585

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01556585

Keywords

Search

Navigation